Valuation: Stryker Corporation

Market Cap 133B 2,315B 117B 109B 99.88B 187B 12,694B 190B 1,288B 504B 6,295B 499B 488B 21,751B P/E 2026 *
27.5x
P/E 2027 * 24x
Enterprise Value 142B 2,471B 124B 116B 107B 200B 13,546B 203B 1,375B 538B 6,718B 532B 521B 23,210B EV / Sales 2026 *
5.2x
EV / Sales 2027 * 4.68x
Free-Float
94.62%
Yield 2026 *
1.01%
Yield 2027 * 1.1%
1 day+2.10%
1 week+2.47%
Current month+1.69%
1 month+8.41%
3 months+2.97%
6 months-2.01%
Current year-8.13%
1 week 5,758.63
Extreme 5758.63
5,879.57
1 month 5,463
Extreme 5463
5,879.57
Current year 5,025
Extreme 5025
6,769.22
1 year 5,025
Extreme 5025
7,293.22
3 years 4,663.01
Extreme 4663.01
8,216
5 years 3,953.6
Extreme 3953.6
8,216
10 years 2,469
Extreme 2469
8,216
Manager TitleAgeSince
Chief Executive Officer 60 01/10/2012
Director of Finance/CFO 50 01/04/2025
President 49 01/01/2026
Director TitleAgeSince
Director/Board Member 82 01/01/1974
Director/Board Member 71 01/01/1984
Chairman 60 22/07/2014
Change 5-day change 1-year change 3-year change Capi.($)
+2.10%+2.47% - - 129B
+3.27%+6.71%+2.48%+0.97% 13.01B
-0.38%-1.15%+59.43%+98.21% 8.92B
+1.19%+5.60%-44.17%-69.43% 4.65B
+0.75%-.--%-.--%+16.65% 3.63B
-2.12%-1.89%-1.61%+35.57% 2.68B
-1.19%+0.88%-26.36%-34.82% 1.63B
+4.50%+8.93%+8.05%-53.34% 1.63B
+0.38%-1.97%-18.67%-25.95% 1.61B
+2.04%-0.99%-60.25%-82.00% 1.47B
Average +1.05%+0.45%-9.01%-12.68% 4.36B
Weighted average by Cap. +1.91%+1.47%+5.21%+10.60%

Financials

2026 *2027 *
Net sales 27.26B 475B 23.92B 22.28B 20.49B 38.41B 2,604B 39.07B 264B 103B 1,292B 102B 100B 4,462B 29.59B 516B 25.97B 24.18B 22.24B 41.69B 2,827B 42.41B 287B 112B 1,402B 111B 109B 4,844B
Net income 4.81B 83.75B 4.22B 3.93B 3.61B 6.77B 459B 6.89B 46.6B 18.24B 228B 18.04B 17.65B 787B 5.53B 96.36B 4.85B 4.52B 4.16B 7.79B 528B 7.93B 53.62B 20.99B 262B 20.76B 20.31B 905B
Net Debt 8.92B 155B 7.82B 7.29B 6.7B 12.56B 852B 12.78B 86.44B 33.83B 422B 33.47B 32.75B 1,459B 5.63B 98.15B 4.94B 4.6B 4.23B 7.94B 538B 8.07B 54.61B 21.38B 267B 21.15B 20.69B 922B
Logo Stryker Corporation
Stryker Corporation is one of the world's leaders in designing, manufacturing and marketing medical equipment and devices in the fields of medical surgery, neurotechnology and orthopaedics. Net sales break down by family of products as follows: - surgical equipment and neurotechnology products (62.3%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipment, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (37.7%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2025, the group had 55 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (75.7%), Europe/Middle East/Africa (12.7%), Asia/Pacific (8.6%) and other (3%).
Employees
56,000
Date Price Change Volume
27/07/26 MXN 5,879.57 +2.10% 264
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
346.60USD
Average target price
387.04USD
Spread / Average Target
+11.67%

Quarterly revenue - Rate of surprise